238 related articles for article (PubMed ID: 34274176)
21. A role for panendoscopy? Second primary tumour in early stage squamous cell carcinoma of the oral tongue.
Koo K; Harris R; Wiesenfeld D; Iseli TA
J Laryngol Otol; 2015 Jan; 129 Suppl 1():S27-31. PubMed ID: 25656280
[TBL] [Abstract][Full Text] [Related]
22. Contralateral neck failure in lateralized oral squamous cell carcinoma.
Habib M; Murgasen J; Gao K; Ashford B; Shannon K; Ebrahimi A; Clark JR
ANZ J Surg; 2016 Mar; 86(3):188-92. PubMed ID: 26138827
[TBL] [Abstract][Full Text] [Related]
23. Adjuvant radiotherapy is not supported in patients with verrucous carcinoma of the oral cavity.
Mohan S; Pai SI; Bhattacharyya N
Laryngoscope; 2017 Jun; 127(6):1334-1338. PubMed ID: 28150306
[TBL] [Abstract][Full Text] [Related]
24. Outcomes for recurrent oral cavity squamous cell carcinoma: A comprehensive outlook.
Reghunadhan P; Hegde S; Thakur S; Subash A; Rao VUS
Oral Oncol; 2023 Aug; 143():106440. PubMed ID: 37290381
[No Abstract] [Full Text] [Related]
25. Hypervascular floor of mouth tumor: Rare presentation of oral cavity squamous cell carcinoma.
Thomas MC; Viaud-Murat EM; Bahra L; Ludwig BR; Kadakia SP
Am J Otolaryngol; 2024; 45(1):104046. PubMed ID: 37741024
[TBL] [Abstract][Full Text] [Related]
26. The frequency of occult cervical metastasis in oral squamous cell carcinoma patients - A cross sectional study.
Haseeb AA; Rahim AU; Iqbal S; Batool H; Younas S; Jawaad Manzoor HM
J Pak Med Assoc; 2022 Jan; 72(1):66-70. PubMed ID: 35099441
[TBL] [Abstract][Full Text] [Related]
27. THE EPIDEMIOLOGY OF LIP, ORAL, AND PHARYNGEAL CANCERS, AND THE ASSOCIATION WITH SELECTED SYSTEMIC DISEASES.
KELLER AZ
Am J Public Health Nations Health; 1963 Aug; 53(8):1214-28. PubMed ID: 14051257
[No Abstract] [Full Text] [Related]
28. Synchronous oral squamous cell carcinoma and a lymphoproliferative disorder in an adult: a challenge in diagnosis and management.
Van der Groen T; Shupak RP; Kim RY
BMJ Case Rep; 2022 Feb; 15(2):. PubMed ID: 35135796
[TBL] [Abstract][Full Text] [Related]
29. LIHNCS - Lugol's iodine in head and neck cancer surgery: a multicentre, randomised controlled trial assessing the effectiveness of Lugol's iodine to assist excision of moderate dysplasia, severe dysplasia and carcinoma in situ at mucosal resection margins of oral and oropharyngeal squamous cell carcinoma: study protocol for a randomised controlled trial.
McCaul JA; Cymerman JA; Hislop S; McConkey C; McMahon J; Mehanna H; Shaw R; Sutton DN; Dunn J
Trials; 2013 Sep; 14():310. PubMed ID: 24063578
[TBL] [Abstract][Full Text] [Related]
30. Cytologic features of oral squamous cell carcinoma in an Indo-Pacific bottlenose dolphin (Tursiops aduncus): Papanicolaou stain and immunocytochemistry using liquid-based cytology.
Ohsaki H; Ueda K; Minakawa T; Oshiro M; Kamoshida S; Sugiura Y; Suzuki M; Nishiyama A
Vet Clin Pathol; 2021 Sep; 50(3):404-409. PubMed ID: 34472131
[TBL] [Abstract][Full Text] [Related]
31. Methuosis - A promising lead for the treatment of oral squamous cell carcinoma.
Krishnan RP; Ramani P; Pandiar D
J Stomatol Oral Maxillofac Surg; 2023 Feb; 124(1S):101333. PubMed ID: 36402427
[No Abstract] [Full Text] [Related]
32. Risk of multiple primary tumors following oral squamous-cell carcinoma.
Jovanovic A; van der Tol IG; Schulten EA; Kostense PJ; de Vries N; Snow GB; van der Waal I
Int J Cancer; 1994 Feb; 56(3):320-3. PubMed ID: 8314317
[TBL] [Abstract][Full Text] [Related]
33. Basaloid squamous cell carcinoma of the oral cavity: an analysis of 92 cases.
Fritsch VA; Gerry DR; Lentsch EJ
Laryngoscope; 2014 Jul; 124(7):1573-8. PubMed ID: 23946211
[TBL] [Abstract][Full Text] [Related]
34. Oral Cavity Cancer: Risk Factors, Pathology, and Management.
Ernani V; Saba NF
Oncology; 2015; 89(4):187-95. PubMed ID: 26088938
[TBL] [Abstract][Full Text] [Related]
35. Oral cancer in Australia: Rising incidence and worsening mortality.
Sun A; Sharma D; Choi SW; Ramamurthy P; Thomson P
J Oral Pathol Med; 2023 Apr; 52(4):328-334. PubMed ID: 36852511
[TBL] [Abstract][Full Text] [Related]
36. Survival outcomes following modern multidisciplinary management of oral squamous cell carcinoma in Australia.
Liu TPJ; Fisher BM; Chua B; Clark JR; Low TH; Batstone MD
Oral Surg Oral Med Oral Pathol Oral Radiol; 2021 Jan; 131(1):92-98. PubMed ID: 33187950
[TBL] [Abstract][Full Text] [Related]
37. Overview of oral cavity squamous cell carcinoma: Risk factors, mechanisms, and diagnostics.
Chamoli A; Gosavi AS; Shirwadkar UP; Wangdale KV; Behera SK; Kurrey NK; Kalia K; Mandoli A
Oral Oncol; 2021 Oct; 121():105451. PubMed ID: 34329869
[TBL] [Abstract][Full Text] [Related]
38. Changing patterns of failure of head and neck cancer.
Taneja C; Allen H; Koness RJ; Radie-Keane K; Wanebo HJ
Arch Otolaryngol Head Neck Surg; 2002 Mar; 128(3):324-7. PubMed ID: 11886352
[TBL] [Abstract][Full Text] [Related]
39. [Squamous cell carcinoma as the most common oral carcinoma. Diagnosis and therapy].
Balakirski G; Hölzle F; Megahed M
Hautarzt; 2014 May; 65(5):390-2. PubMed ID: 24820795
[TBL] [Abstract][Full Text] [Related]
40. Periodontal pathogens are a risk factor of oral cavity squamous cell carcinoma, independent of tobacco and alcohol and human papillomavirus.
Ganly I; Yang L; Giese RA; Hao Y; Nossa CW; Morris LGT; Rosenthal M; Migliacci J; Kelly D; Tseng W; Hu J; Li H; Brown S; Pei Z
Int J Cancer; 2019 Aug; 145(3):775-784. PubMed ID: 30671943
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
